ArticleCancer immunology, immunotherapy : CII2021

Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.

Jun Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.